Huntington's Disease Treatment Market predicted to grow at a CAGR of 38.2%

The global  Huntington's disease treatment market is predicted to reach USD 1.5 billion by 2023, growing at a CAGR of 38.2 percent over that time. Factors like as increasing absorption of disease-modifying medicines, greater adoption of innovative therapeutics, and expanded R&D activities are driving the market.



Huntington's disease is a hereditary neurodegenerative condition with motor, cognitive, and mental symptoms. Xenazine and Austedo are the only two symptom-relieving treatments currently licensed for this disease. Because there are no approved alternatives, off-label drugs are frequently used.

As disease-modifying medications disrupt the commercial landscape, the Huntington's disease pipeline is projected to grow rapidly in the next years. With a better understanding of the condition, treatment methods aiming at altering particular alterations connected to the underlying mutation have made great progress.
The potential involvement of RNA antisense technology and stem cell therapy is now being researched in clinical trials. Antisense oligonucleotides from Wave Life Sciences and Ionis Pharma aim to target the underlying disease cause and are likely to contribute considerably to market growth.

Growing Adoption of Improved Medications and Therapies to Drive the Demand for Effective Treatments

The involvement of leading industry participants in the search for a cure for Huntington's disease (HD) is expected to contribute to market growth. This can be ascribed to the growing patient population and disease incidence over the world, particularly in North America and Europe. The unmet need for disease-modifying medications and other treatment modalities for HD is expected to have a positive impact on market growth in the future.

Growing Research and Development Activities to Raise the Market Growth

There is tremendous scope for the study and development of Huntington's disease treatment market approaches because there is no proper treatment or medication. Over the forecast period, this is expected to significantly boost the market growth. Furthermore, prospective government measures to boost the development of novel pharmaceuticals are expected to contribute to market growth.

Restraints

Limited Availability of Drugs to Hamper the Market Growth

Because of tight standards and regulations, the number of licensed medications for Huntington's disease is restricted. Over the projection period, this is expected to stifle market growth. Furthermore, Huntington's disease treatment market expansion is expected to be limited by a lack of understanding of the ailment in many regions of the world.


Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

YOU YES YOU!

Key Benefits of Breath Analyzer Market